Denali Therapeutics Stock Predictions

The Tech Disruption Wall Street Isn't Talking About...Yet

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Sell

DNLI
Denali Therapeutics

Last Price:

26.52

Seasonality Move:

19.03%

7 Day Trial

ALL ACCESS PASS

$ 7

Why Over 21,997 Investors Are Flocking to This Opportunity

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Denali Therapeutics Stock Forecast

Over the next 52 weeks, Denali Therapeutics has on average historically risen by 22.6% based on the past 6 years of stock performance.
Denali Therapeutics has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Is Denali Therapeutics Stock Undervalued?
The current Denali Therapeutics [DNLI] share price is $26.72. The Score for DNLI is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
DNLI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Denali Therapeutics Stock Go Up Next Year?

Over the next 52 weeks, Denali Therapeutics has on average historically risen by 22.6% based on the past 6 years of stock performance.

Denali Therapeutics Stock Rating

Sell

Denali Therapeutics (DNLI) is a Sell

Is Denali Therapeutics overpriced?

Denali Therapeutics has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Denali Therapeutics Stock Price History

Is DNLI stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DNLI is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

denalitherapeutics.com

52-Week Data

52-Week High:

32.13

52-Week Low:

14.56

Prediction Charts

Market Cap:

3.83B

Price in USD:

26.72

Volume:

436.47K

Beta:

1.56

Technical Analysis

SMA50:

26.03

SMA100:

23.78

SMA200:

21.21

52-Wk Change:

27.79%

Stock Predictions

Is Denali Therapeutics stock public?
Yes, Denali Therapeutics is a publicly traded company.
What is the Denali Therapeutics stock quote today?
The Denali Therapeutics stock price is 26.72 USD today.
How to buy Denali Therapeutics stock online?
You can buy Denali Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Sep-19	31.70	31.08	31.94	30.82
Sep-20	30.94	30.92	31.24	30.65
Sep-23	31.23	30.24	31.28	30.23
Sep-24	30.24	30.32	30.51	29.58
Sep-25	30.52	29.00	30.54	28.93
Sep-26	29.37	29.27	29.64	28.83
Sep-27	29.50	29.43	29.80	29.22
Sep-30	29.12	29.13	29.32	28.50
Oct-1	29.18	28.69	29.67	28.46
Oct-2	28.37	29.03	29.07	28.02
Oct-3	28.69	28.22	28.88	28.12
Oct-4	28.51	28.63	28.97	28.38
Oct-7	27.89	26.60	27.89	26.22
Oct-8	26.68	26.72	27.47	26.30

Denali Therapeutics Earnings

Denali Therapeutics Earnings Report: Per Share Denali Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Denali Therapeutics Forecast Revenue Growth

Denali Therapeutics Stock Analysis: Historical quarterly revenues per share for Denali Therapeutics and historical quarterly revenue growth:

Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.52 per share, and a decrease next year of $0.10 per share.

* Denali Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.